Gyre Therapeutics, Inc. (GYRE): R&D Expense
$13.70M
Year ended 2025-12-31
-6.4%
3-year compound annual growth
-23.7%
5-year compound annual growth
+8.7%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.70M | +13.9% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $12.02M | -12.7% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $13.78M | -17.4% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | $16.69M | -75.8% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $68.89M | +30.0% | 2022-03-31, From 2021-01-01 |
| 2020-12-31 | $52.98M | +20.8% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $43.86M | +104.2% | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | $21.47M | +67.2% | 2020-02-20, From 2018-01-01 |
| 2017-12-31 | $12.85M | +11.2% | 2019-03-08, From 2017-01-01 |
| 2016-12-31 | $11.55M | +93.9% | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | $5.96M | +13.1% | 2017-03-08, From 2015-01-01 |
| 2014-12-31 | $5.27M | -19.7% | 2016-03-09, From 2014-01-01 |
| 2013-12-31 | $6.56M | -86.6% | 2016-03-09, From 2013-01-01 |
| 2012-12-31 | $49.09M | -48.4% | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | $95.22M | +47.5% | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | $64.55M | +60.6% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $40.18M | n/a | 2012-03-06, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $13.70M | +13.9% |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | $67.11M | +17.4% |
| Xencor Inc (XNCR) | 2025-12-31 | $239.43M | +5.2% |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $37.41M | -0.6% |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $12.74M | -69.7% |
| Zymeworks Inc. (ZYME) | 2025-12-31 | $137.00M | +1.8% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.26M | -3.7% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $19.96M | +62.1% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $125.62M | -12.3% |
Compare GYRE, URGN, XNCR, TBPH side by side · Screen every company in Pharmaceutical Preparations ↗